- Home
- ILAG vs CYCN Comparison
ILAG vs CYCN Comparison
Compare ILAG & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ILAG | CYCN |
|---|---|---|
| Founded | 1981 | 2018 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Office Equipment/Supplies/Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.9M | 6.5M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | ILAG | CYCN |
|---|---|---|
| Price | $3.85 | $1.50 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 35.2K | ★ 4.4M |
| Earning Date | 12-22-2025 | 03-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $5,338,785.00 | $2,855,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 1371.65 |
| 52 Week Low | $2.74 | $1.16 |
| 52 Week High | $9.80 | $6.25 |
Technical Indicators
Market Signals| Indicator | ILAG | CYCN |
|---|---|---|
| Relative Strength Index (RSI) | 67.33 | 50.80 |
| Support Level | $3.74 | $1.33 |
| Resistance Level | $4.20 | $1.69 |
| Average True Range (ATR) | 0.28 | 0.20 |
| MACD | -0.10 | -0.00 |
| Stochastic Oscillator | 41.36 | 20.71 |
Price Performance
Historical ComparisonAbout ILAG Intelligent Living Application Group Inc.
Intelligent Living Application Group Inc focuses on designing and producing affordable, high-quality locksets and smart security systems. The company offers high-quality mechanical locksets and smart locks to its customers. Its product portfolio comprises various ODM indoor and outdoor locksets, such as deadbolts, entry locksets, privacy locksets, passage locksets, and storeroom locks, which are marketed through brands like Kambo and Bamberg. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada.
About CYCN Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.